SEK 215.5
(0.47%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 59.4 Million EUR | 2.06% |
2022 | 58.2 Million EUR | -19.17% |
2021 | 72 Million EUR | 35.85% |
2020 | 53 Million EUR | 42.86% |
2019 | 37.1 Million EUR | 22.44% |
2018 | 30.3 Million EUR | -1.3% |
2017 | 30.7 Million EUR | 18.99% |
2016 | 25.8 Million EUR | 6.61% |
2015 | 24.2 Million EUR | 90.55% |
2014 | 12.7 Million EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 61 Million EUR | 2.69% |
2024 Q2 | 66.2 Million EUR | 8.52% |
2023 Q2 | 54.6 Million EUR | 3.8% |
2023 FY | 59.4 Million EUR | 2.06% |
2023 Q4 | 59.4 Million EUR | 9.59% |
2023 Q1 | 52.6 Million EUR | -9.62% |
2023 Q3 | 54.2 Million EUR | -0.73% |
2022 Q1 | 67.4 Million EUR | -6.39% |
2022 Q4 | 58.2 Million EUR | -9.06% |
2022 Q3 | 64 Million EUR | 0.16% |
2022 Q2 | 63.9 Million EUR | -5.19% |
2022 FY | 58.2 Million EUR | -19.17% |
2021 Q1 | 52.9 Million EUR | -0.19% |
2021 Q4 | 72 Million EUR | 19.8% |
2021 Q2 | 55.1 Million EUR | 4.16% |
2021 FY | 72 Million EUR | 35.85% |
2021 Q3 | 60.1 Million EUR | 9.07% |
2020 Q4 | 53 Million EUR | 38.38% |
2020 Q1 | 38.6 Million EUR | 4.04% |
2020 Q2 | 35.7 Million EUR | -7.51% |
2020 Q3 | 38.3 Million EUR | 7.28% |
2020 FY | 53 Million EUR | 42.86% |
2019 Q2 | 32.6 Million EUR | 6.19% |
2019 FY | 37.1 Million EUR | 22.44% |
2019 Q4 | 37.1 Million EUR | 9.76% |
2019 Q3 | 33.8 Million EUR | 3.68% |
2019 Q1 | 30.7 Million EUR | 1.32% |
2018 Q1 | 33.2 Million EUR | 8.14% |
2018 Q4 | 30.3 Million EUR | 13.91% |
2018 Q3 | 26.6 Million EUR | -1.85% |
2018 Q2 | 27.1 Million EUR | -18.37% |
2018 FY | 30.3 Million EUR | -1.3% |
2017 Q4 | 30.7 Million EUR | 16.29% |
2017 FY | 30.7 Million EUR | 18.99% |
2017 Q1 | 25.1 Million EUR | -2.71% |
2017 Q2 | 25.3 Million EUR | 0.8% |
2017 Q3 | 26.4 Million EUR | 4.35% |
2016 Q1 | - EUR | 0.0% |
2016 Q4 | 25.8 Million EUR | 0.0% |
2016 FY | 25.8 Million EUR | 6.61% |
2015 FY | 24.2 Million EUR | 90.55% |
2014 FY | 12.7 Million EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Xvivo Perfusion AB (publ) | 141.6 Million SEK | 58.052% |